SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-21-000400
Filing Date
2021-08-23
Accepted
2021-08-23 12:44:09
Documents
41
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 06-30-2021 form_10-q.htm   iXBRL 10-Q 689483
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 10332
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 5083
  Complete submission text file 0001161697-21-000400.txt   3174582

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA gstc-20210630.xsd EX-101.SCH 21855
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gstc-20210630_cal.xml EX-101.CAL 32036
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gstc-20210630_def.xml EX-101.DEF 120711
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE gstc-20210630_lab.xml EX-101.LAB 223367
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION gstc-20210630_pre.xml EX-101.PRE 179317
9 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 394947
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 206-451-1970
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 211196113
SIC: 2834 Pharmaceutical Preparations